[DOI] [PubMed] [Google Scholar] 40.Zheng Z, Zong Y, Ma Y, et al
Preliminary studies suggest that GLP-1 receptor agonists may offer benefits in neurological conditions like Alzheimers disease, substance use disorders, polycystic ovary syndrome (PCOS), and even non-alcoholic steatohepatitis (NASH)
Legal Pressure from Pharmaceutical Giants Novo Nordisk has filed multiple lawsuits targeting compounding pharmacies, as reported by Reuters
The carbohydrate restriction of ketogenic diets further reduces glucose availability, potentially necessitating medication adjustments
What Are the Biggest Nutrition Concerns for People Taking GLP-1s
Step 1: Check Your Eligibility Age 18 years or older Some platforms require 21+ BMI BMI 30 OR BMI 27 with a weight-related comorbidity Examples of qualifying comorbidities: Hypertension Type 2 diabetes Sleep apnea Medical History Requirements You may not qualify if you have: Personal or family history of MTC or MEN2 Active or recent pancreatitis Pregnancy or breastfeeding Severe kidney disease State Availability Must reside in a state where provider coverage is available Checked automatically during intake BMI is calculated as: weight (lbs) / height (inches)^2 703 If you have a documented weight-related health condition and your BMI is 2729.9, that condition must be disclosed in your intake it may determine eligibility
